How do you approach worsening memory loss in patients with GCA?

Join the Discussion

Discuss the cases and questions guidelines don't cover.

Related Questions

Can cryoglobulins be present in the setting of severe acrocyanosis without evidence of active cryoglobulinemic vasculitis?

Do you taper or stop avacopan in patients with ANCA-associated vasculitis once remission is achieved?

2

Has the January 2026 FDA-requested voluntary withdrawal of avacopan, citing concerns about clinical trial data and potential safety risks, changed your prescribing practices?

What is your approach to management of severe recurrent exercise induced vasculitis?

How do you assess for flare of giant cell arteritis in a patient on tocilizumab where inflammatory markers may be suppressed by TCZ?

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
Mobile App

Company

About
Careers
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service